The DLC-1 tumor suppressor was first revealed in this study as a potential modulator of the surface markers of hMSCs, the CD105 in particular, suggesting it may be associated with overall quality of hMSCs, as CD105 is involved in multiple functions of hMSCs, including osteogenic differentiation [8, 34], angiogenesis [35], and regenerative/therapeutic potential [36]. Here, ENG is linked to neoplasm.